CAU
PBH icon

Caxton Associates (UK)’s Prestige Consumer Healthcare PBH Stock Holding History

Caxton Associates (UK)’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$446K Buy
+9,438
New +$485K 0.01% 553
2026
Q1 		– Sell
-11,984
Closed -$739K – 951
2025
Q4 		$739K Buy
+11,984
New +$734K 0.01% 420

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caxton Associates (UK)'s PBH Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Prestige Consumer Healthcare (PBH) in Q2 2026: 9,438 shares worth $446K. The stake represents 0.01% of the portfolio and ranks #553 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in PBH as recently as Q4 2025.

Caxton Associates (UK) first reported a position in PBH in Q4 2025 and has held it in 2 quarters since. The position peaked at $739K in Q4 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Caxton Associates (UK) held 9,438 shares of Prestige Consumer Healthcare worth $446K as of Q2 2026.
  • Prestige Consumer Healthcare was a new Caxton Associates (UK) position in Q2 2026.
  • Prestige Consumer Healthcare made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #553 holding.
  • Caxton Associates (UK) first reported a position in Prestige Consumer Healthcare in Q4 2025 and has held it in 2 quarters since.
  • Caxton Associates (UK)'s Prestige Consumer Healthcare position peaked at $739K in Q4 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.